{
  "pack_version": "ud-trial-provenance/0.1",
  "pack_id": "tpp-271593f186bf276b8b6e7e8d",
  "generated_at": "2026-09-21T15:03:41.767Z",
  "trial": {
    "canonical_trial_id": "NCT02428335",
    "registry": "ClinicalTrials.gov",
    "registry_url": "https://clinicaltrials.gov/study/NCT02428335",
    "first_seen_at": "2026-09-21T15:03:41.262Z",
    "last_checked_at": "2026-09-21T15:03:41.262Z"
  },
  "fields": {
    "brief_title": "Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib",
    "official_title": "Evaluation of Technetium-99m Sestamibi to Determine Muscle Energy Metabolism in RCC (Renal Cell Cancer) Patients Treated With Sunitinib",
    "overall_status": "WITHDRAWN",
    "phase": [],
    "sponsor": "AHS Cancer Control Alberta",
    "collaborators": [],
    "enrollment": 0,
    "enrollment_type": "ACTUAL",
    "interventions": [],
    "conditions": [
      "Renal Cell Cancer",
      "Fatigue"
    ],
    "primary_outcomes": [
      {
        "measure": "99mTc-sestamibi uptake in muscle cells",
        "timeFrame": "12 weeks from start of treatment"
      },
      {
        "measure": "99mTc-sestamibi uptake in muscle cells",
        "timeFrame": "24 weeks from start of treatment"
      },
      {
        "measure": "99mTc-sestamibi uptake in muscle cells",
        "timeFrame": "36 weeks from start of treatment"
      }
    ],
    "secondary_outcomes": [
      {
        "measure": "Incidence of sunitinib related fatigue",
        "timeFrame": "36 weeks after the start of sunitinib treatment"
      }
    ],
    "start_date": "2015-06",
    "primary_completion_date": "2019-03-18",
    "study_completion_date": "2019-03-18",
    "study_type": "OBSERVATIONAL"
  },
  "sources": [
    {
      "source_id": "src-dbf2612c0f5024a721cc",
      "source_type": "CLINICALTRIALS_GOV_RECORD",
      "tier": 1,
      "canonical_url": "https://clinicaltrials.gov/study/NCT02428335",
      "external_identifier": "NCT02428335",
      "publisher": "U.S. National Library of Medicine",
      "published_at": null,
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "content_hash": "f44e555288074ca87bb72cb9b879f5d5c6a1e55726b1559ea26e2f36b6f8cbbb",
      "snapshot_locator": null,
      "status": "CURRENTLY_RETRIEVED"
    }
  ],
  "observations": [
    {
      "trial_id": "NCT02428335",
      "field_name": "brief_title",
      "normalized_value": "Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib",
      "raw_value": "Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib",
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "22c745e9713150d75937e9272f30988aff098040b9a722d2d8b848409adc6525"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "official_title",
      "normalized_value": "Evaluation of Technetium-99m Sestamibi to Determine Muscle Energy Metabolism in RCC (Renal Cell Cancer) Patients Treated With Sunitinib",
      "raw_value": "Evaluation of Technetium-99m Sestamibi to Determine Muscle Energy Metabolism in RCC (Renal Cell Cancer) Patients Treated With Sunitinib",
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "db61593a11144e3bd179a7af7584d5e82e928302077899bb187eb02055eb8f6a"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "overall_status",
      "normalized_value": "WITHDRAWN",
      "raw_value": "WITHDRAWN",
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "5807ffe681bd3692acea39a3a2a0304f370f2ffbdf27ffab3ec42ef10667f4df"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "phase",
      "normalized_value": [],
      "raw_value": [],
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "a8d41aadaae72415c60a2f7135c6415612b443576ffa11b84c7ccabc4f5992bd"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "sponsor",
      "normalized_value": "AHS Cancer Control Alberta",
      "raw_value": "AHS Cancer Control Alberta",
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "400e30ead2faabb897e158447ace122d186082317d926114f10b0c0f04da22bf"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "collaborators",
      "normalized_value": [],
      "raw_value": [],
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "650d830f85193bdd91e09f7fa1a2b1c8eb41150f7a20a62a92c119af3f71af5f"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "enrollment",
      "normalized_value": 0,
      "raw_value": 0,
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "5cc0716521547d94d4dbfc5a3e6283c59ced48681548469402d7dbb1d8e880a1"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "enrollment_type",
      "normalized_value": "ACTUAL",
      "raw_value": "ACTUAL",
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "b0ac9f957bee391235d8fd8813f3a66d317b7e31c5c623ca43a2d017aec6a508"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "interventions",
      "normalized_value": [],
      "raw_value": [],
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "712f196b074b460e95cbf44be48c9ade50ace84bf04a39eedb9958efd6cf4c9c"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "conditions",
      "normalized_value": [
        "Renal Cell Cancer",
        "Fatigue"
      ],
      "raw_value": [
        "Renal Cell Cancer",
        "Fatigue"
      ],
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "fe5b400732033b43688697ddbbb076ab2e2b5ffab91e0f8d4d454de4fc14627d"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "primary_outcomes",
      "normalized_value": [
        {
          "measure": "99mTc-sestamibi uptake in muscle cells",
          "timeFrame": "12 weeks from start of treatment"
        },
        {
          "measure": "99mTc-sestamibi uptake in muscle cells",
          "timeFrame": "24 weeks from start of treatment"
        },
        {
          "measure": "99mTc-sestamibi uptake in muscle cells",
          "timeFrame": "36 weeks from start of treatment"
        }
      ],
      "raw_value": [
        {
          "measure": "99mTc-sestamibi uptake in muscle cells",
          "timeFrame": "12 weeks from start of treatment"
        },
        {
          "measure": "99mTc-sestamibi uptake in muscle cells",
          "timeFrame": "24 weeks from start of treatment"
        },
        {
          "measure": "99mTc-sestamibi uptake in muscle cells",
          "timeFrame": "36 weeks from start of treatment"
        }
      ],
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "6d6530fe0c7f60758b4a886ecbef51256ed56dfc3439a9d956dae056eeb85428"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "secondary_outcomes",
      "normalized_value": [
        {
          "measure": "Incidence of sunitinib related fatigue",
          "timeFrame": "36 weeks after the start of sunitinib treatment"
        }
      ],
      "raw_value": [
        {
          "measure": "Incidence of sunitinib related fatigue",
          "timeFrame": "36 weeks after the start of sunitinib treatment"
        }
      ],
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "7cd82ca6e1a4bd425ae5e31fe8df6e3988f3971bbb8cb42501c2ae3baf2e3a32"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "start_date",
      "normalized_value": "2015-06",
      "raw_value": "2015-06",
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "a3266a950302c972c029a3b499a1c849be56dcc826cc1c3f96186d5ebd73ed3b"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "primary_completion_date",
      "normalized_value": "2019-03-18",
      "raw_value": "2019-03-18",
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "66bc2e1d62e119c5738842bf616ddc435faa7add2daf5581e19927e6dcbea75b"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "study_completion_date",
      "normalized_value": "2019-03-18",
      "raw_value": "2019-03-18",
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "5c96edddeb56a5bc62bb7ad48abfa261f801c32e50e0939f8ae0315c25b66fa9"
    },
    {
      "trial_id": "NCT02428335",
      "field_name": "study_type",
      "normalized_value": "OBSERVATIONAL",
      "raw_value": "OBSERVATIONAL",
      "source_id": "src-dbf2612c0f5024a721cc",
      "retrieved_at": "2026-09-21T15:03:41.262Z",
      "observation_hash": "50d3d7f689c1d87f2252ccdf44272be4836c399e8d74fdfe7592ad52bbd74ad9"
    }
  ],
  "claims": [
    {
      "claim_id": "claim-f20f7d6c57b55d658a24",
      "subject": "NCT02428335",
      "predicate": "brief_title",
      "value": "Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib",
      "normalized_value": "Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib",
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-9e069add48c425e40f40",
      "subject": "NCT02428335",
      "predicate": "official_title",
      "value": "Evaluation of Technetium-99m Sestamibi to Determine Muscle Energy Metabolism in RCC (Renal Cell Cancer) Patients Treated With Sunitinib",
      "normalized_value": "Evaluation of Technetium-99m Sestamibi to Determine Muscle Energy Metabolism in RCC (Renal Cell Cancer) Patients Treated With Sunitinib",
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-d57de35530155fc81cf5",
      "subject": "NCT02428335",
      "predicate": "overall_status",
      "value": "WITHDRAWN",
      "normalized_value": "WITHDRAWN",
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-f1eb2bf4c50fd835338d",
      "subject": "NCT02428335",
      "predicate": "phase",
      "value": [],
      "normalized_value": [],
      "claim_type": "UNKNOWN",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-a97dc5431045842c3537",
      "subject": "NCT02428335",
      "predicate": "sponsor",
      "value": "AHS Cancer Control Alberta",
      "normalized_value": "AHS Cancer Control Alberta",
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-ebde3f336cbe1955c381",
      "subject": "NCT02428335",
      "predicate": "collaborators",
      "value": [],
      "normalized_value": [],
      "claim_type": "UNKNOWN",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-64600493ab92f64987c5",
      "subject": "NCT02428335",
      "predicate": "enrollment",
      "value": 0,
      "normalized_value": 0,
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-7cb731506c0f0676260e",
      "subject": "NCT02428335",
      "predicate": "enrollment_type",
      "value": "ACTUAL",
      "normalized_value": "ACTUAL",
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-4e2dc67563132167ec0e",
      "subject": "NCT02428335",
      "predicate": "interventions",
      "value": [],
      "normalized_value": [],
      "claim_type": "UNKNOWN",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-1bc8f07f8b64aa85dfbb",
      "subject": "NCT02428335",
      "predicate": "conditions",
      "value": [
        "Renal Cell Cancer",
        "Fatigue"
      ],
      "normalized_value": [
        "Renal Cell Cancer",
        "Fatigue"
      ],
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-5e74858ea9e114d3432d",
      "subject": "NCT02428335",
      "predicate": "primary_outcomes",
      "value": [
        {
          "measure": "99mTc-sestamibi uptake in muscle cells",
          "timeFrame": "12 weeks from start of treatment"
        },
        {
          "measure": "99mTc-sestamibi uptake in muscle cells",
          "timeFrame": "24 weeks from start of treatment"
        },
        {
          "measure": "99mTc-sestamibi uptake in muscle cells",
          "timeFrame": "36 weeks from start of treatment"
        }
      ],
      "normalized_value": [
        {
          "measure": "99mTc-sestamibi uptake in muscle cells",
          "timeFrame": "12 weeks from start of treatment"
        },
        {
          "measure": "99mTc-sestamibi uptake in muscle cells",
          "timeFrame": "24 weeks from start of treatment"
        },
        {
          "measure": "99mTc-sestamibi uptake in muscle cells",
          "timeFrame": "36 weeks from start of treatment"
        }
      ],
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-327998bb4adcffd2a726",
      "subject": "NCT02428335",
      "predicate": "secondary_outcomes",
      "value": [
        {
          "measure": "Incidence of sunitinib related fatigue",
          "timeFrame": "36 weeks after the start of sunitinib treatment"
        }
      ],
      "normalized_value": [
        {
          "measure": "Incidence of sunitinib related fatigue",
          "timeFrame": "36 weeks after the start of sunitinib treatment"
        }
      ],
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-76e709eebadc6d6d0265",
      "subject": "NCT02428335",
      "predicate": "start_date",
      "value": "2015-06",
      "normalized_value": "2015-06",
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-e6baa342f76e5252ed97",
      "subject": "NCT02428335",
      "predicate": "primary_completion_date",
      "value": "2019-03-18",
      "normalized_value": "2019-03-18",
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-c1ef42653e120c8a97e3",
      "subject": "NCT02428335",
      "predicate": "study_completion_date",
      "value": "2019-03-18",
      "normalized_value": "2019-03-18",
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    },
    {
      "claim_id": "claim-c6c0e8c546d35c326c57",
      "subject": "NCT02428335",
      "predicate": "study_type",
      "value": "OBSERVATIONAL",
      "normalized_value": "OBSERVATIONAL",
      "claim_type": "SOURCE_FACT",
      "observed_at": "2026-09-21T15:03:41.262Z",
      "created_at": "2026-09-21T15:03:41.262Z"
    }
  ],
  "claim_support": [
    {
      "claim_id": "claim-f20f7d6c57b55d658a24",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.identificationModule.briefTitle",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    },
    {
      "claim_id": "claim-9e069add48c425e40f40",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.identificationModule.officialTitle",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    },
    {
      "claim_id": "claim-d57de35530155fc81cf5",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.statusModule.overallStatus",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    },
    {
      "claim_id": "claim-a97dc5431045842c3537",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    },
    {
      "claim_id": "claim-64600493ab92f64987c5",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.designModule.enrollmentInfo.count",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    },
    {
      "claim_id": "claim-7cb731506c0f0676260e",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.designModule.enrollmentInfo.type",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    },
    {
      "claim_id": "claim-1bc8f07f8b64aa85dfbb",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.conditionsModule.conditions",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    },
    {
      "claim_id": "claim-5e74858ea9e114d3432d",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.outcomesModule.primaryOutcomes",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    },
    {
      "claim_id": "claim-327998bb4adcffd2a726",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.outcomesModule.secondaryOutcomes",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    },
    {
      "claim_id": "claim-76e709eebadc6d6d0265",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.statusModule.startDateStruct.date",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    },
    {
      "claim_id": "claim-e6baa342f76e5252ed97",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.statusModule.primaryCompletionDateStruct.date",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    },
    {
      "claim_id": "claim-c1ef42653e120c8a97e3",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.statusModule.completionDateStruct.date",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    },
    {
      "claim_id": "claim-c6c0e8c546d35c326c57",
      "source_id": "src-dbf2612c0f5024a721cc",
      "exact_locator": "protocolSection.designModule.studyType",
      "relationship": "SUPPORTS",
      "confidence": 1,
      "reviewer_state": "DIRECT_STRUCTURED_FIELD"
    }
  ],
  "publications": [],
  "changes": [],
  "contradictions": [],
  "unknowns": [
    "phase",
    "collaborators",
    "interventions"
  ],
  "evidence_manifest": {
    "manifest_version": "ud-trial-provenance/0.1",
    "pack_id": "tpp-271593f186bf276b8b6e7e8d",
    "trial_id": "NCT02428335",
    "generated_at": "2026-09-21T15:03:41.767Z",
    "software_version": "0.1.0",
    "policy_version": "clinical-trial-provenance/0.1",
    "ordered_sources": [
      {
        "source_id": "src-dbf2612c0f5024a721cc",
        "canonical_url": "https://clinicaltrials.gov/study/NCT02428335",
        "retrieved_at": "2026-09-21T15:03:41.262Z",
        "content_hash": "f44e555288074ca87bb72cb9b879f5d5c6a1e55726b1559ea26e2f36b6f8cbbb",
        "tier": 1
      }
    ],
    "claims_digest": "2bc5ba60f0e6632fb242a89871ecba8e3f36b96b6c4c94d9ce76ca9e3a55cdef",
    "field_observations_digest": "91ec1adb0797c778f5d7a9ef339de193df05cbafe2a34a3a74b83bb3b74e8146",
    "change_events_digest": "4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945",
    "contradictions_digest": "4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945",
    "trust_state": {
      "integrity": "INTEGRITY VERIFIED",
      "signer_identity": "NOT CHECKED",
      "timestamp": "LOCAL SIGNED TIME ONLY",
      "current_status": "NOT CHECKED",
      "transparency": "NOT PRESENT"
    },
    "manifest_digest": "cc92525cacc22b9890237e5cbeb2f8dd7621043b2e4583a87989d135b936e688"
  }
}